Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma

Published:2010-10 Issue:10 Volume:21 Page:2069-2074
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Niitsu N.,Okamoto M.,Tamaru J.-i.,Yoshino T.,Nakamura N.,Nakamura S.,Ohshima K.,Nakamine H.,Hirano M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/10/2069/897460/mdq057.pdf

Reference19 articles.

1. De novo CD5+ diffuse large B-cell lymphoma: clinicopathologic study of 109 patients;Yamaguchi;Blood,2002

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

3. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Volume 2: IARC WHO Classification of Tumours, No 2;Sterdlow,2008

4. Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma;Niitsu;Ann Haematol,2006

5. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray;Hans;Blood,2004

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CD5+ diffuse large B-cell lymphoma;Annals of Hematology;2024-08-28

2. Long-term remission after upfront autologous hematopoietic stem cell transplant for CD5 ⁺ diffuse large-B cell lymphoma;Journal of Chemotherapy;2024-04-23

3. CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition;Journal of Clinical Oncology;2024-02-01

4. Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins;Clinical Proteomics;2023-09-13

5. Misdiagnosis analysis of 2291 cases of haematolymphoid neoplasms;Frontiers in Oncology;2023-04-26